Neural Therapeutics Inc. (CSE:NURL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0250
+0.0050 (25.00%)
At close: Dec 5, 2025

Neural Therapeutics Company Description

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada.

The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine.

Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021.

Neural Therapeutics Inc. was founded in 2020 and is headquartered in Toronto, Canada.

Neural Therapeutics Inc.
Country Canada
Founded 2020
Industry Biological Products, Except Diagnostic Substances
CEO Ian Campbell

Contact Details

Address:
130 Adelaide Street West
Toronto, Ontario M5H 3P5
Canada
Phone 647-697-6875
Website neuraltherapeutics.ca

Stock Details

Ticker Symbol NURL
Exchange Canadian Securities Exchange
Fiscal Year August - July
Reporting Currency CAD
SIC Code 2836

Key Executives

Name Position
Ian Campbell Chief Executive Officer
Omar Gonzalez Chief Financial Officer